The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
Open accessAbstract
Antimicrobial drug development is increasingly lagging behind the evolution of antibiotic resistance, and as a result, there is a pressing need for new antibacterial therapies that can be readily designed and implemented. In this work, we engineered bacteriophage to overexpress proteins and attack gene networks that are not directly targeted by antibiotics. We show that suppressing the SOS network in Escherichia coli with engineered bacteriophage enhances killing by quinolones by several orders of magnitude in vitro and significantly increases survival of infected mice in vivo. In addition, we demonstrate that engineered bacteriophage can enhance the killing of antibiotic-resistant bacteria, persister cells, and biofilm cells, reduce the number of antibiotic-resistant bacteria that arise from an antibiotic-treated population, and act as a strong adjuvant for other bactericidal antibiotics (e.g., aminoglycosides and β-lactams). Furthermore, we show that engineering bacteriophage to target non-SOS gene networks and to overexpress multiple factors also can produce effective antibiotic adjuvants. This work establishes a synthetic biology platform for the rapid translation and integration of identified targets into effective antibiotic adjuvants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yanisch-Perron, C., Vieira, J., & Messing, J. (1985) · Gene · doi:10.1016/0378-1119(85)90120-9 · Cited by 15,041
Bacterial biofilms: from the Natural environment to infectious diseases
Hall-Stoodley, L., Costerton, J. W., & Stoodley, P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro821 · Cited by 7,143
Antibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982 · cited 19×
“SoxR contains a [2Fe-2S] cluster that must be oxidized for it to stimulate SoxS production, which then controls the transcription of downstream genes that respond to oxidative stress (31).”
BackgroundMethodResultInfluentialSelf-citationBacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952 · cited 4×
“Letters in Applied Microbiology 37(4):318–323.”
BackgroundInfluentialProduction of the antimalarial drug precursor artemisinic acid in engineered yeast
Ro, D.-K., Paradise, E. M., Ouellet, M., Fisher, K. J., Newman, K. L., Ndungu, J. M., Ho, K. A., Eachus, R. A., Ham, T. S., Kirby, J., et al. (2006) · Nature · doi:10.1038/nature04640 · Cited by 2,805
The challenge of emerging and re-emerging infectious diseases
Morens, D. M., Folkers, G. K., & Fauci, A. S. (2004) · Nature · doi:10.1038/nature02759 · Cited by 2,103
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052 · cited 2×
“Nature Reviews Microbiology 2(5):430–435.”
BackgroundMutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli
Walker, G. C. (1984) · Microbiological Reviews · doi:10.1128/mmbr.48.1.60-93.1984 · Cited by 1,770
Lutz, R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.6.1203 · Cited by 1,693
Synthetic biology: new engineering rules for an emerging discipline
Andrianantoandro, E., Basu, S., Karig, D. K., & Weiss, R. (2006) · Molecular Systems Biology · doi:10.1038/msb4100073 · Cited by 1,081
Dispersing biofilms with engineered enzymatic bacteriophage
Lu, T. K., & Collins, J. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704624104 · Cited by 895
Self-citationWhere will new antibiotics come from?
Walsh, C. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro727 · Cited by 755
Hasty, J., McMillen, D., & Collins, J. J. (2002) · Nature · doi:10.1038/nature01257 · Cited by 742
Self-citationMutation Frequencies and Antibiotic Resistance
Martinez, J. L., & Baquero, F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1771-1777.2000 · Cited by 694
SOS Response Induction by ß-Lactams and Bacterial Defense Against Antibiotic Lethality
Miller, C., Thomsen, L. E., Gaggero, C., Mosseri, R., Ingmer, H., & Cohen, S. N. (2004) · Science · doi:10.1126/science.1101630 · Cited by 584
Inhibition of Mutation and Combating the Evolution of Antibiotic Resistance
Cirz, R. T., Chin, J. K., Andes, D. R., de Crécy-Lagard, V., Craig, W. A., & Romesberg, F. E. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030176 · Cited by 576
Kohanski, M. A., Dwyer, D. J., Wierzbowski, J., Cottarel, G., & Collins, J. J. (2008) · Cell · doi:10.1016/j.cell.2008.09.038 · Cited by 574
Self-citationEnvironmentally Controlled Invasion of Cancer Cells by Engineered Bacteria
Anderson, J. C., Clarke, E. J., Arkin, A. P., & Voigt, C. A. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.076 · Cited by 572
Strong Purifying Selection in Transmission of Mammalian Mitochondrial DNA
Stewart, J. B., Freyer, C., Elson, J. L., Wredenberg, A., Cansu, Z., Trifunovic, A., & Larsson, N.-G. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060010 · Cited by 524
Long-circulating bacteriophage as antibacterial agents.
Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S., & Adhya, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3188 · Cited by 512
Evaluating treatment protocols to prevent antibiotic resistance
Bonhoeffer, S., Lipsitch, M., & Levin, B. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12106 · Cited by 487
Summers, W. C. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.437 · Cited by 474
Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli
Dwyer, D. J., Kohanski, M. A., Hayete, B., & Collins, J. J. (2007) · Molecular Systems Biology · doi:10.1038/msb4100135 · Cited by 469
Self-citationAntibiotic interactions that select against resistance
Chait, R., Craney, A., & Kishony, R. (2007) · Nature · doi:10.1038/nature05685 · Cited by 439
Biofilm Formation and Dispersal under the Influence of the Global Regulator CsrA of Escherichia coli
Jackson, D. W., Suzuki, K., Oakford, L., Simecka, J. W., Hart, M. E., & Romeo, T. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.1.290-301.2002 · Cited by 425
OxyR and SoxRS Regulation of fur
Zheng, M., Doan, B., Schneider, T. D., & Storz, G. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.15.4639-4643.1999 · Cited by 403
The prospect for bacteriophage therapy in Western medicine
Merril, C. R., Scholl, D., & Adhya, S. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1111 · Cited by 367
Chan, L. Y., Kosuri, S., & Endy, D. (2005) · Molecular Systems Biology · doi:10.1038/msb4100025 · Cited by 357
A bottom-up approach to gene regulation
Guido, N. J., Wang, X., Adalsteinsson, D., McMillen, D., Hasty, J., Cantor, C. R., Elston, T. C., & Collins, J. J. (2006) · Nature · doi:10.1038/nature04473 · Cited by 326
Self-citationDeans, T. L., Cantor, C. R., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.05.045 · Cited by 275
Self-citationA linguistic model for the rational design of antimicrobial peptides
Loose, C., Jensen, K., Rigoutsos, I., & Stephanopoulos, G. (2006) · Nature · doi:10.1038/nature05233 · Cited by 247
SoxR, a [2Fe-2S] transcription factor, is active only in its oxidized form.
Gaudu, P., & Weiss, B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10094 · Cited by 234
Westwater, C., Kasman, L. M., Schofield, D. A., Werner, P. A., Dolan, J. W., Schmidt, M. G., & Norris, J. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1301-1307.2003 · Cited by 214
Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage
Hagens, S., Habel, A., von Ahsen, U., von Gabain, A., & Bläsi, U. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3817-3822.2004 · Cited by 187
Engineering Life: Building a FAB for Biology
Baker, D., Church, G., Collins, J., Endy, D., Jacobson, J., Keasling, J., Modrich, P., Smolke, C., & Weiss, R. (2006) · Scientific American · doi:10.1038/scientificamerican0606-44 · Cited by 174
Self-citationPredicting the evolution of antibiotic resistance genes
Hall, B. G. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro888 · Cited by 167
Advances in synthetic biology: on the path from prototypes to applications
McDaniel, R., & Weiss, R. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2005.07.002 · Cited by 157
Hidalgo, E., Ding, H., & Demple, B. (1997) · Cell · doi:10.1016/s0092-8674(00)81864-4 · Cited by 146
Phage typing of Salmonella enteritidis in the United States
Hickman-Brenner, F. W., Stubbs, A. D., & Farmer, J. J. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.12.2817-2823.1991 · Cited by 142
Genetically modified filamentous phage as bactericidal agents: a pilot study
Hagens, S., & Bläsi, U. (2003) · Letters in Applied Microbiology · doi:10.1046/j.1472-765x.2003.01400.x · Cited by 109
Preparation of endotoxin-free bacteriophages.
Boratyński, J., Syper, D., Weber‐Dąbrowska, B., Łusiak-Szelachowska, M., Poźniak, G., & Górski, A. (2004) · PubMed · Cited by 99
4-Quinolones and the SOS response
Lewin, C. S., Howard, B. M. A., Ratcliff, N. T., & Smith, J. T. (1989) · Journal of Medical Microbiology · doi:10.1099/00222615-29-2-139 · Cited by 87
Hidalgo, E., Leautaud, V., & Demple, B. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2629 · Cited by 75
Bringing DNA Computers to Life
Shapiro, E. Y., & Benenson, Y. (2007) · Scientific American A Matter of Time · doi:10.1038/scientificamerican0907-40sp · Cited by 69
Shapiro, E. Y., & Benenson, Y. (2006) · PubMed · Cited by 22
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Self-citationA brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628
Synthetic biology: applications come of age
Khalil, A. S., & Collins, J. J. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2775 · Cited by 1,373
Self-citationA century of the phage: past, present and future
Salmond, G. P. C., & Fineran, P. C. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3564 · Cited by 823
Metadata
- Authors
- Lu, T. K., & Collins, J. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-03-24
- Volume
- 106
- Issue
- 12
- Pages
- 4629-4634
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2013330518
- Cited by
- 529
- References
- 47
- FWCI
- 29.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.